La cadena de opciones muestra datos clave de las opciones de acciones de Renovaro a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Renovaro..

Renovaro (NASDAQ:RENB) Bolsa, Cadena de Opciones

Renovaro Biosciences

Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.

Renovaro Inc

renBTC

Truist Securities analyst Michael Swartz maintains Winnebago Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WGO#NYSE">WGO</a>) with a Buy and lowers the price target from $40 to $36.

News

Price Target

Analyst Ratings

Truist Securities Maintains Buy on Winnebago Industries, Lowers Price Target to $36

Viatris Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTRS#NASDAQ">VTRS</a>) and Opus Genetics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRD#NASDAQ">IRD</a>) revealed topline results from VEGA-3, the second pivotal Phase 3 trial evaluating MR-141 (phentolamine ophthalmic solution 0.75%) <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">for presbyopia</a>.
Presbyopia is the gradual loss of near-focusing ability due to aging that typically becomes noticeable in the early to mid-40s. It is a nearly universal condition that, when uncorrected, contributes significantly to <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/n46111517/viatris-announces-positive-top-line-results-from-second-pivotal-phase-3-vega-3-trial-of-mr-141-in-" rel="noreferrer noopener">vision-related disability</a>.
It affects nearly 128 million people in the United States, about 90% of adults over 45. By age 50, most Americans require some form of near-vision correction, such as reading glasses or multifocal lenses.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/initiation/25/06/45820489/goldman-sachs-bullish-on-branded-drug-upside-at-teva-what-about-viatris" rel="noreferrer noopener">Goldman Sachs Bullish On Branded Drug Upside At Teva: What About Viatris?</a>
Viatris Chief R&amp;D Officer Philippe Martin said, &#8220;We are pleased with the positive results from the second pivotal Phase 3 trial, which reinforce our confidence in MR-141 and its benefit-risk profile as a potential, non-invasive option to support the millions of patients impacted by this condition.&#8221;
Significantly more patients treated in the MR-141 arm achieved the primary endpoint of Early Treatment Diabetic Retinopathy Study (ETDRS) (≥3-line) gain in binocular distance-corrected near visual acuity (DCNVA) and with less than five letters of loss in binocular best-corrected distance visual acuity (BCDVA) from baseline at 12 hours post-dose on Day 8, compared to placebo (p&lt;0.0001).
More patients treated in the MR-141 arm achieved ≥15-letters ETDRS (≥3-line) gain in DCNVA and with less than five letters of loss in BCDVA at 1-hour post-dose on Day 1 compared to those receiving placebo (p=0.0002).
Significant patient-reported functional benefits at Days 3, 8, and Week 6 were observed, with patients reporting satisfaction with near vision upon awakening (p&lt;0.0001) and satisfaction with their improvement in near vision (p&lt;0.0001).
Patient reported significant improvement in near vision in dim/low light at Days 3, 8 and Week 6 compared with placebo (p&lt;0.0001).
During the 6-week follow-up, no evidence of tachyphylaxis (an acute, sudden decrease in response to a drug) was observed.
MR-141 demonstrated a safety profile consistent with previous trials. No new safety signal was identified, and no treatment-related serious adverse events were reported in this study.
The most common (≥5%) treatment-emergent adverse events included conjunctival hyperemia, instillation site irritation, and dysgeusia, which were predominantly mild. A low rate of headache (2.6%) was reported over the study period.&nbsp;
Price Action: VTRS stock is up 1.97% at $9.065, and IRD stock is trading higher by 5.13% to $1.02 at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/reiteration/25/06/46119135/tesla-set-for-rebound-thanks-to-robotaxis-and-strong-cash-flow-analyst" target="_blank" rel="noreferrer noopener">Tesla Set For Rebound Thanks To Robotaxis And Strong Cash Flow: Analyst</a></li>
</ul>
Photo via Shutterstock

Biotech

Health Care

General

VTRS

Viatris Eye Drops Data Shows Promise For Blurred Near Vision

Truist Securities analyst Michael Ciarmoli initiates coverage on Redwire (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) with a Hold rating and announces Price Target of $16.

Initiation

Truist Securities Initiates Coverage On Redwire with Hold Rating, Announces Price Target of $16

Company to Exit Molded Fiber Business; Additional Facility Changes Planned
MEMPHIS, Tenn., June 26, 2025 /PRNewswire/ -- International&nbsp;Paper (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IP#NYSE">IP</a>, LSE: IPC))), a global leader in sustainable packaging, today announced a series of strategic changes to strengthen its North American operations and better serve customers.
As part of this initiative, the company will:
<ul>
<li>Exit the molded fiber business and convert the Reno, Nev. facility to support its packaging business</li>
<li>Close its packaging facility in Marion, Ohio</li>
<li>Close its recycling facility in Wichita, Kan.</li>
<li>Sell its containerboard mill in Xalapa, Mexico and its recycling plants in Xalapa and Apodaca, Mexico to Acabados de Papeles Santinados y Absorbentes (APSA).</li>
</ul>
In the U.S., these changes will impact approximately 110 hourly and 24 salaried employees. In Mexico, APSA intends to retain current onsite team members at each location. International Paper is committed to minimizing the impact through job placement in existing vacancies, retirements and other internal opportunities. Affected employees will also receive severance and outplacement support where possible.

International Paper To Exit Molded Fiber Business And Convert Reno, Nev. Facility To Support Its Packaging Business

<a href="https://www.bloomberg.com/news/articles/2025-06-26/bbva-favors-proceeding-with-sabadell-bid-if-investors-agree">https://www.bloomberg.com/news/articles/2025-06-26/bbva-favors-proceeding-with-sabadell-bid-if-investors-agree</a>

BBVA

'BBVA Favors Proceeding With Sabadell Bid If Investors Agree'- Bloomberg

Energy markets are in a bit of flux at the moment.
Last week, the idea of $120 oil and continued disruption from the Middle East conflict was at the top of expert minds.
This week, we seem to be back to everlasting peace, bliss, everlasting cooperation, rainbows, unicorns, and prosperity for all.
Oil prices have begun falling again, and the same experts who warned of spikes last week now expect to see crude back into the upper 50s.
Here is what I know about crude oil. The market has had a failed rally and is now back below the 50-week moving average by a smidge (highly technical term). Cash prices are opening right at the 200 days moving average.
For now Crude is still in a bearish mode in spite of last week's volatility related to the Iranian difficulties
Hedging volume by US producers soared last week as prices rose. Even as they locked in higher prices for future delivery, many producers were also buying out of the money call options just in case things got a little dodgier in Iran.
Producers were hedging and speculating a bit on a sustained conflict, but there is another group who looked at the price of the energy-related businesses they operate recently and decided that no matter what happened in the Middle East, the price of their stock was just too low.
The High-Yield Play: Mach Natural Resources (Ticker: MACH)
Sometimes the market serves up opportunities that seem almost too good to be true. Mach Natural Resources is one of those situations that demands a closer look, if only because of that eye-popping 15% plus distribution yield.
Mach operates in the Anadarko Basin, focusing on natural gas production across Western Oklahoma, Southern Kansas, and the Texas panhandle. This is not some wildcat exploration story. They are working proven reserves in established fields, which reduces the geological risk that plagues many energy ventures. The company went public in 2023, making it relatively new to the public markets but not new to the business of extracting hydrocarbons from the ground.
What immediately catches your attention is the ownership structure. William Wallace McMullen owns nearly 72% of the company, with Bayou City Energy Management controlling 66% overall. This level of insider ownership is unusual in public markets and suggests management has serious skin in the game. When McMullen dropped $4 million to buy another 280,400 shares this month, he was not making a token gesture.
The company has a variable dividend policy that over the last year has paid out over 18% in dividends. Yields that high usually signal either exceptional value or exceptional risk. In Mach&#8217;s case, analysts believe it is the former. Five analysts covering the stock have unanimous &#8220;Strong Buy&#8221; ratings with price targets averaging $24, suggesting 81% upside from current levels.
The company reported $0.61 in earnings per unit for the first quarter, slightly missing expectations but still generating substantial cash flow. Management projects $2.31 per unit in free cash flow for 2025, which provides reasonable coverage for the distribution at current commodity prices. The key phrase there is &#8220;current commodity prices.&#8221; Natural gas has been volatile, and Mach&#8217;s fortunes are tied directly to those price movements.
From a balance sheet perspective, Mach carries a debt-to-equity ratio of 0.64 with a current ratio of 1.24, indicating reasonable financial health. The return on equity of 24.33% reflects the leverage inherent in the business model, while the 14.53% return on invested capital suggests efficient managements.
The risk here is obvious: natural gas prices. If prices remain depressed, that distribution becomes unsustainable quickly. But with analysts projecting higher natural gas prices in 2025 and the company&#8217;s low-cost production profile, Mach appears positioned to benefit from any commodity recovery.
The Deep Value Turnaround: Amplify Energy (Ticker: AMPY)
While Mach offers high current income, Amplify Energy presents a classic deep value opportunity with the potential for substantial capital appreciation. The stock has been beaten down significantly, trading near its 52-week low of $2.58 after reaching $8.15 earlier in the cycle. Sometimes the market&#8217;s pessimism creates opportunity.
Amplify operates across multiple regions, giving it geographic diversification that many smaller energy companies lack. Their assets span Oklahoma, the Rockies, federal waters offshore Southern California, East Texas, North Louisiana, and the Eagle Ford. The California offshore operation, known as the Beta field, represents significant potential upside but requires oil prices above $60 per barrel to justify development.
The first quarter results told an interesting story. While revenue of $72 million slightly missed expectations, earnings per share of $3.80 crushed analyst estimates of $0.21. This dramatic outperformance suggests the company&#8217;s operational improvements are gaining traction. Management has focused on cost reduction and cash flow improvement, with debt reduction being a primary goal.
What really gets my attention is the insider activity. In the past 30days, insiders have purchased 391,176 shares worth $1.31 million. Last week director Christopher Hamm bought 77,176 shares at $3.67, while COO Daniel Furbee added 10,000 shares at $2.97 at the end of May. When management is backing up their optimism with personal capital, it is worth paying attention.
The analyst community sees substantial upside. With price targets ranging from $8.50 to $11.00 and an average of $9.67, the Street is pricing in 150% upside potential. Seven analysts have issued buy ratings with zero holds or sells in the current month. This level of optimism from professionals who have studied the company&#8217;s assets suggests the current price reflects excessive pessimism.
The Steady Eddie: ConocoPhillips (Ticker: COP)
If Mach and Amplify represent the more speculative end of energy investing, ConocoPhillips stands as the sector&#8217;s steady performer. With a $121 billion market cap, this is one of the world&#8217;s largest independent exploration and production companies, offering global diversification and operational scale that smaller companies cannot match.
ConocoPhillips operates across six segments spanning Alaska to Asia Pacific, but their crown jewel remains the Lower 48 operations. They produce 833 thousand barrels of oil equivalent per day from the Permian Basin alone, making them a major player in America&#8217;s most important shale field. Add in 296 thousand barrels daily from the Eagle Ford and 151 thousand from the Bakken, and you are looking at a company with tier-one assets in tier-one basins.
The first quarter showed the company&#8217;s resilience. Despite a 6% decline in realized prices to $53.34 per barrel, production increased 487 thousand barrels daily year-over-year to 2.389 million barrels equivalent. This volume growth helped deliver $2.8 billion in earnings, up from $2.6 billion in the prior year. Management&#8217;s ability to grow production while reducing both capital expenditure guidance to $12.3-12.6 billion and operating cost guidance to $10.7-10.9 billion demonstrates operational excellence.
What sets ConocoPhillips apart is their shareholder-friendly capital allocation. The quarterly dividend of $0.78 per share yields 3.58% annually, with a sustainable payout ratio of 38.98%. Management raised the dividend 34% in the third quarter of 2024, signaling confidence in cash flow sustainability. Beyond dividends, the company returned $9.1 billion to shareholders in 2024, including $5.5 billion in share buybacks.
The share repurchase program deserves particular attention. Management increased their authorization by $20 billion and plans to return $10 billion to shareholders in 2025. At current prices, this represents meaningful ownership accretion for remaining shareholders. When combined with the dividend, total shareholder yield approaches impressive levels.
Recent insider activity reinforces management confidence. Executive Vice President Kirk Johnson purchased 5,300 shares at $94.24 last week, investing nearly $500,000 of personal capital.
Institutional ownership exceeds 75%, with JPMorgan Chase holding 47.2 million shares and Price T. Rowe Associates owning 40.3 million shares. Berkshire Hathaway&#8217;s continued position adds Warren Buffett&#8217;s implicit endorsement to the investment thesis.
Eighteen Wall Street analysts cover the stock with a strong buy consensus, setting price targets averaging $113.50 with a range from $95 to $130. This suggests 20-21% upside potential, which when combined with the 3.58% dividend yield, offers attractive total return prospects.
Insiders have been slowly accumulating energy stocks for several months now.
This is not about end demand and pricing for crude oil and natural gas over the next few months.
It is about the growing demand we will ss over rh next several decades.

Opinion

AMPY

Alpha Buying: Volatility Be Damned—These Energy Stocks Have a Plan

<h3>Gainers</h3>
<ul>
<li>Live Ventures (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIVE#NASDAQ">LIVE</a>) stock moved upwards by 83.6% to $15.51 during Thursday's regular session. The company's market cap stands at $25.9 million. </li>
<li>Genius Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GNS#AMEX">GNS</a>) shares rose 37.95% to $1.02. The market value of their outstanding shares is at $52.9 million. </li>
<li>QuantumScape (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>) stock rose 25.94% to $7.14. The company's market cap stands at $3.1 billion. </li>
<li>Sypris Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYPR#NASDAQ">SYPR</a>) shares moved upwards by 19.15% to $2.42. The market value of their outstanding shares is at $46.6 million. </li>
<li>Jeffs Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFBR#NASDAQ">JFBR</a>) shares rose 18.92% to $7.73. The market value of their outstanding shares is at $3.5 million. </li>
<li>Lead Real Estate Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRE#NASDAQ">LRE</a>) shares moved upwards by 14.24% to $1.85. The market value of their outstanding shares is at $22.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Autozi Internet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZI#NASDAQ">AZI</a>) shares decreased by 21.5% to $0.21 during Thursday's regular session. The company's market cap stands at $30.3 million. </li>
<li>Mullen Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) shares fell 20.56% to $0.71. </li>
<li>EZGO Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZGO#NASDAQ">EZGO</a>) stock declined by 8.8% to $0.31. The company's market cap stands at $1.9 million. </li>
<li>SRM Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRM#NASDAQ">SRM</a>) shares decreased by 8.47% to $7.95. The company's market cap stands at $154.7 million. </li>
<li>QuantaSing Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSG#NASDAQ">QSG</a>) stock decreased by 8.36% to $8.56. The market value of their outstanding shares is at $477.3 million. </li>
<li>Outdoor Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWWP#NASDAQ">POWWP</a>) shares decreased by 8.23% to $21.1. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

EZGO

JFBR

LIVE

MULN

POWWP

SYPR

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) shares increased by 93.0% to $1.07 during Thursday's regular session. The company's market cap stands at $69.2 million. </li>
<li>Adial Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADIL#NASDAQ">ADIL</a>) stock increased by 47.03% to $0.36. The company's market cap stands at $3.8 million. </li>
<li>bioAffinity Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIAF#NASDAQ">BIAF</a>) stock rose 35.26% to $0.33. The market value of their outstanding shares is at $6.6 million. </li>
<li>Kewaunee Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KEQU#NASDAQ">KEQU</a>) stock increased by 30.7% to $52.91. The market value of their outstanding shares is at $115.5 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Aspire Biopharma Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASBP#NASDAQ">ASBP</a>) stock rose 28.17% to $0.31. The company's market cap stands at $11.8 million. </li>
<li>Synaptogenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPX#NASDAQ">SNPX</a>) stock increased by 26.12% to $4.75. The market value of their outstanding shares is at $5.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Altimmune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>) shares declined by 55.4% to $3.44 during Thursday's regular session. The company's market cap stands at $625.3 million. </li>
<li>Reviva Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVPH#NASDAQ">RVPH</a>) stock decreased by 50.51% to $0.38. The company's market cap stands at $35.6 million. </li>
<li>Liminatus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) stock declined by 22.54% to $18.57. The market value of their outstanding shares is at $623.8 million. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) shares declined by 19.81% to $6.29. The company's market cap stands at $4.4 million. </li>
<li>Eyenovia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) shares decreased by 17.13% to $7.91. The company's market cap stands at $27.5 million. </li>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock decreased by 17.1% to $0.03. The company's market cap stands at $12.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADIL

ASBP

BIAF

EYEN

GCTK

HCTI

KEQU

LIMN

RVPH

SNPX

12 Health Care Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Surf Air Mobility (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRFM#NYSE">SRFM</a>) shares increased by 33.7% to $3.4 during Thursday's regular session. The market value of their outstanding shares is at $48.9 million. </li>
<li>ESS Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWH#NYSE">GWH</a>) stock rose 22.42% to $1.31. The market value of their outstanding shares is at $12.9 million. </li>
<li>JVSPAC Acquisition Corp. - Right (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JVSAR#NASDAQ">JVSAR</a>) shares moved upwards by 22.33% to $0.63. </li>
<li>Enovix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVX#NASDAQ">ENVX</a>) shares increased by 20.18% to $10.48. The market value of their outstanding shares is at $1.6 billion. </li>
<li>AIRO Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRO#NASDAQ">AIRO</a>) shares moved upwards by 20.0% to $26.28. The company's market cap stands at $545.3 million. </li>
<li>BlackSky Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKSY#NYSE">BKSY</a>) stock increased by 17.41% to $20.29. The company's market cap stands at $541.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Globavend Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) shares declined by 72.9% to $0.19 during Thursday's regular session. The company's market cap stands at $10.4 million. </li>
<li>New Horizon Aircraft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOVR#NASDAQ">HOVR</a>) stock decreased by 17.69% to $1.4. The market value of their outstanding shares is at $53.3 million. </li>
<li>OceanPal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) shares decreased by 12.34% to $1.99. The market value of their outstanding shares is at $17.0 million. </li>
<li>Phoenix Asia Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHOE#NASDAQ">PHOE</a>) shares decreased by 11.81% to $9.79. The market value of their outstanding shares is at $239.7 million. </li>
<li>Fuel Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEK#NASDAQ">FTEK</a>) shares fell 9.43% to $2.5. The market value of their outstanding shares is at $84.9 million. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) stock decreased by 8.96% to $0.31. The market value of their outstanding shares is at $78.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRO

BlackSky Technology Inc. Class A Common Stock

BKSY

ENVX

FTEK

HOVR

JVSAR

LNZA

PHOE

SRFM

12 Industrials Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) stock increased by 331.9% to $21.64 during Thursday's regular session. The company's market cap stands at $8.7 million. </li>
<li>Ascent Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTI#NASDAQ">ASTI</a>) shares rose 148.06% to $2.89. The market value of their outstanding shares is at $2.1 million. </li>
<li>Sonim Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONM#NASDAQ">SONM</a>) shares increased by 30.15% to $1.64. The market value of their outstanding shares is at $13.0 million. </li>
<li>Core Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>) shares rose 23.94% to $15.24. The company's market cap stands at $3.6 billion. </li>
<li>Youxin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YAAS#NASDAQ">YAAS</a>) shares moved upwards by 18.19% to $5.68. The company's market cap stands at $161.3 million. </li>
<li>BigBear.ai Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) stock increased by 17.56% to $5.66. The market value of their outstanding shares is at $1.3 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Bit Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBT#NASDAQ">BTBT</a>) stock decreased by 18.7% to $1.91 during Thursday's regular session. The company's market cap stands at $490.0 million. </li>
<li>Next Technology Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTT#NASDAQ">NXTT</a>) shares decreased by 15.02% to $2.15. The market value of their outstanding shares is at $1.1 billion. </li>
<li>Aeluma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALMU#NASDAQ">ALMU</a>) shares decreased by 14.58% to $14.56. The market value of their outstanding shares is at $269.1 million. </li>
<li>Diginex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGNX#NASDAQ">DGNX</a>) shares declined by 12.4% to $44.32. The company's market cap stands at $1.1 billion. </li>
<li>3 E Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASK#NASDAQ">MASK</a>) shares fell 12.27% to $2.77. The market value of their outstanding shares is at $35.5 million. </li>
<li>Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) shares fell 11.66% to $0.51. The company's market cap stands at $90.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALMU

ASTI

BBAI

BTBT

Core Scientific, Inc. - Class A Common Stock

CORZ

DGNX

MASK

Next Technology Holding Inc. - Ordinary Shares

NXTT

SONM

WOLF

YAAS

12 Information Technology Stocks Moving In Thursday's Intraday Session

Keefe, Bruyette &amp; Woods analyst Jade Rahmani maintains KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) with a Market Perform and lowers the price target from $65 to $58.

Keefe, Bruyette & Woods Maintains Market Perform on KB Home, Lowers Price Target to $58

<a href="https://x.com/pulte/status/1938280767370502643">https://x.com/pulte/status/1938280767370502643</a>
<figure class="image"><img src="https://pbs.twimg.com/media/GuYoFToWkAAHf6p?format=jpg&amp;name=small" alt="Image" /></figure>

FMCC

FNMA

U.S. Director Of Federal Housing FHFA Bill Pulte Posts On X "One of Fannie & Freddie's most undervalued assets is a little known company "CSS". It being little known changes TODAY! We've created U.S. Fin Tech to hold CSS and sell our MBS Fin Tech Services to others - thanks to President Trump, this will unlock so much value for America!"

NIO Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) is reportedly preparing to launch operations in Hong Kong in the fourth quarter of this year, adopting a <a href="https://www.benzinga.com/movers">distributor-led model instead of direct sales</a>.
The move will place NIO in direct <a href="https://www.tesla.com/findus/list/stores/Hong%20Kong">competition </a>with EV heavyweight Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), which already holds a strong foothold<a href="https://www.benzinga.com/25/05/45510669/tesla-supplier-catl-soars-125-in-46-billion-hong-kong-ipo"> in the Hong Kong market.</a>
The move signals a strategic shift by the electric vehicle maker as it expands into global markets with lower capital intensity, CnEV Post <a target="_blank" href="https://cnevpost.com/2025/06/26/nio-to-enter-hk-q4/" rel="noreferrer noopener">reports</a>, citing local media.
The company intends to mirror its Macau approach in Hong Kong by partnering with a local distributor rather than establishing its own retail network, the report adds.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/46022793/nio-sets-stage-for-chip-arm-spin-off-eyes-external-clients-report" rel="noreferrer noopener">NIO Sets Stage For Chip Arm Spin-Off, Eyes External Clients: Report</a>
CnEV Post noted that this asset-light model will also be adopted in new markets such as Azerbaijan and Brazil.
NIO will formally introduce its new Macau distribution partner, Guangdong Hongyue Automobile Sales Group, on July 1.
Hongyue has been granted exclusive rights to manage market operations, service infrastructure, and ecosystem development across NIO&#8217;s three brands—NIO, Onvo, and Firefly—in the region.
The company previously used a direct-sales approach in Europe but began transitioning to distributor partnerships in late 2023.
Hongyue&#8217;s responsibilities in Macau will include brand promotion and user support.
Although NIO has not officially announced its Macau launch, hundreds of its vehicles already operate in the area, facilitated by the city&#8217;s openness to left-hand drive cars, unlike neighboring Hong Kong.
To support its growing footprint, NIO has built two battery swap stations in Macau—one inaugurated in late 2021 and another in October 2023. These installations hint at the company&#8217;s long-term intentions for the region, even prior to formal distribution deals, CnEV Post adds.
Price Action: NIO shares are trading lower by 1.7% to $3.41 at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46117348/meta-secures-more-clean-energy-for-power-hungry-ai-and-data-center-growth" target="_blank" rel="noreferrer noopener">Meta Secures More Clean Energy For Power Hungry AI And Data Center Growth</a></li>
</ul>
Photo by Tada Images via Shutterstock

Equities

Markets

TSLA

NIO Plots Hong Kong Entry With New Game Plan To Challenge Tesla

Micron Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) shares fell Thursday in early trading, despite the company on Wednesday reporting <a href="https://www.benzinga.com/markets/earnings/25/06/46104401/micron-q3-earnings-revenue-eps-beat-estimates-data-center-revenue-guidance-ai-demand">upbeat fiscal third-quarter earnings</a>.
The announcement came amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
KeyBanc Capital Markets On Micron Technology
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/585beadcb5a482000151d188/john-vinh">Analyst John Vinh</a> reiterated an Overweight rating, while raising the price target from $135 to $160.
Micron Technology reported quarterly revenues and earnings of $9.30 billion and $1.91 per share, beating consensus of $8.86 billion and $1.60 per share, respectively, Vinh said in a note. The results were driven by "improved pricing/mix and healthy demand, particularly for DRAM and HBM," he added.
"Looking into F4Q, MU sees continued strength in AI data center, a recovery in auto/industrials, and tightening DRAM supply driving favorable mix and improving GM," the analyst wrote. For the fiscal fourth quarter, management guided to revenue and earnings of $10.7 billion and $2.50 per share, above the consensus of $9.90 and $2.03 per share, he further wrote.
Piper Sandler On Micron Technology
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58fe05b80bd9910001595370/harsh-kumar">Analyst Harsh Kumar</a> maintained an Overweight rating, while lifting the price target from $120 to $165.
Micron Technology's DRAM and NAND bit shipments both grew around 20% sequentially, Kumar said. The company continued to gain market share with its HBM (high-bandwidth memory) product, he added.
Revenues generated by HBM continued to grow by more than 50% sequentially, the analyst stated. "We continue to see MU as an outsized beneficiary from current market trends in both data center and AI due to their HBM products and market positioning," he further wrote.
<h1 class="wp-block-heading">Stifel On Micron Technology</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58c6ab8cb85e9300015f1add/brian-chin">Analyst Brian Chin</a> reaffirmed a Buy rating, while taking the price target higher from $130 to $145.
Micron Technology announced its results and guidance higher than consensus estimates, Chin said. The company guided to gross margins of 42.0% for the fiscal fourth quarter, "exceeding our 38.0%," he added.
Management noted that data center demand had strengthened the guidance, the analyst stated. "This is expected to drive a more favorable mix, reflected in a better-than expected F4Q GM guide," he further wrote.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
<h1 class="wp-block-heading">RBC Capital Markets On Micron Technology</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5846ee55ee7bf6000154d12b/jonathan-atkin">Analyst Matt Bryson</a> reiterated an Outperform rating, while raising the price target from $150 to $165.
While Micron Technology's sequential growth in bit shipments was strong, expectations were "already in this range," Bryson said. The company's data center revenues more than doubled on a year-on-year basis and reached record levels, he added.
HBM sales grew nearly 50% sequentially to surpass $1.5 billion in the quarter, the analyst stated. The company's HBM ramp "remains on track, with growth in that market in turn lifting MU&#8217;s future revenue and margin profile," he added.
<h1 class="wp-block-heading">Cantor Fitzgerald On Micron Technology</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6331beac10b15f0001b58380/c-j%20muse">Analyst C.J. Muse</a> maintained an Overweight rating, while lifting the price target from $145 to $155.
While Micron Technology was expected to announce a strong beat-and-raise quarter, its results and guidance were "well above just about everyone's expectations," Muse said.
While indicating some tariff-related pre-purchases, management said that secular trends in both data center and HBM memory and a cyclical recovery in NAND were "more important drivers of the recovery," the analyst stated. The company also suggested that "a return to tight/normalized inventory exiting August FY25 sets the stage for a strong recovery to continue through the remainder of CY25 and into FY26," he further wrote.
<h1 class="wp-block-heading">Needham On Marvell Technology</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e21cde3430dee0001c717dd/quinn-bolton">Analyst Quinn Bolton</a> reaffirmed a Buy rating, while taking the price target higher from $120 to $150.
Micron Technology reported solid results and guidance, "driven by continued strength in data center along with a recovery in other end markets," Bolton said. "The AI demand environment remains healthy and Micron continues to increase its share in the HBM market," he added.
The company reported non-GAAP gross margins of 39.0% and guidance to 42.0% at the midpoint, surpassing consensus of 39.2%, the analyst stated. "The GM expansion is attributed to product mix shift towards DRAM from NAND and an improving pricing environment," he further wrote.
MU Price Action: Shares of Micron Technology declined by 1.88% to $124.87 at the time of publication on Thursday.
Read More: • <a href="https://www.benzinga.com/markets/equities/25/06/46111337/micron-ceo-cautions-ai-boom-may-not-be-fully-sustainable-flags-tariff-driven-demand-pull-in">Micron CEO Cautions AI Boom May Not Be Fully Sustainable, Flags Tariff-Driven Demand Pull-In</a>

Photo: Shutterstock

Analyst Color

Earnings

Earnings Beats

Guidance

Reiteration

Trading Ideas

Micron Impresses Wall Street With Strong Q3 Earnings, 'Continued Strength In AI Data Center'

General Dynamics' GDIT Bags $580M Integrated Base Defense Sustainment Support Task Order To Continue Enhancing Security And Readiness Of U.S. Army Bases

AMZN

iShares Dow Jones US Financial Sector Index Fund

TSLX

CNBC Halftime Report Final Trades: Novartis, Amazon, iShares U.S. Financial ETF, Sixth Street Specialty Lending

Deep-pocketed investors have adopted a bullish approach towards JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in JPM usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for JPMorgan Chase. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 37% bearish. Among these notable options, 3 are puts, totaling $133,150, and 5 are calls, amounting to $541,320.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $240.0 and $325.0 for JPMorgan Chase, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for JPMorgan Chase options trades today is 755.43 with a total volume of 529.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for JPMorgan Chase's big money trades within a strike price range of $240.0 to $325.0 over the last 30 days.
<h3>JPMorgan Chase Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750957282_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$26.35</td>
<td>$26.05</td>
<td>$26.35</td>
<td>$280.00</td>
<td>$329.3K</td>
<td>951</td>
<td align="right">131</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$16.1</td>
<td>$16.0</td>
<td>$16.0</td>
<td>$285.00</td>
<td>$78.4K</td>
<td>1.8K</td>
<td align="right">101</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$30.35</td>
<td>$30.1</td>
<td>$30.25</td>
<td>$265.00</td>
<td>$75.6K</td>
<td>1.2K</td>
<td align="right">39</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$37.25</td>
<td>$37.05</td>
<td>$37.25</td>
<td>$325.00</td>
<td>$67.0K</td>
<td>0</td>
<td align="right">26</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$6.15</td>
<td>$6.0</td>
<td>$6.05</td>
<td>$260.00</td>
<td>$36.3K</td>
<td>524</td>
<td align="right">127</td>
</tr>
</tbody>
</table>

<h3>About JPMorgan Chase</h3>
JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with nearly $4 trillion in assets. It is organized into four major segments: consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates, and is subject to regulation, in multiple countries.
Having examined the options trading patterns of JPMorgan Chase, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>JPMorgan Chase's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 4,570,044, the JPM's price is up by 1.68%, now at $288.82. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 19 days.</li>
</ul>
<h3>What Analysts Are Saying About JPMorgan Chase</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $288.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Truist Securities continues to hold a Hold rating for JPMorgan Chase, targeting a price of $280. 
&#x2A; An analyst from B of A Securities has decided to maintain their Buy rating on JPMorgan Chase, which currently sits at a price target of $325. 
&#x2A; Maintaining their stance, an analyst from Citigroup continues to hold a Neutral rating for JPMorgan Chase, targeting a price of $275. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on JPMorgan Chase, which currently sits at a price target of $240. 
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on JPMorgan Chase, maintaining a target price of $320. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for JPMorgan Chase with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

JPMorgan Chase Options Trading: A Deep Dive into Market Sentiment

High-rolling investors have positioned themselves bullish on Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in HOOD often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 13 options trades for Robinhood Markets. This is not a typical pattern.
The sentiment among these major traders is split, with 53% bullish and 15% bearish. Among all the options we identified, there was one put, amounting to $27,300, and 12 calls, totaling $761,540.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $55.0 and $95.0 for Robinhood Markets, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Robinhood Markets stands at 3563.92, with a total volume reaching 7,944.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Robinhood Markets, situated within the strike price corridor from $55.0 to $95.0, throughout the last 30 days.
<h3>Robinhood Markets Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750957277_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$29.9</td>
<td>$29.6</td>
<td>$29.86</td>
<td>$55.00</td>
<td>$164.2K</td>
<td>10.1K</td>
<td>14</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/20/26</td>
<td>$19.85</td>
<td>$19.7</td>
<td>$19.77</td>
<td>$85.00</td>
<td>$98.8K</td>
<td>2.4K</td>
<td>103</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$13.4</td>
<td>$13.4</td>
<td>$13.4</td>
<td>$75.00</td>
<td>$80.4K</td>
<td>9.8K</td>
<td>155</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/11/25</td>
<td>$4.0</td>
<td>$3.9</td>
<td>$4.0</td>
<td>$84.00</td>
<td>$79.9K</td>
<td>455</td>
<td>2.9K</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$31.5</td>
<td>$28.85</td>
<td>$30.13</td>
<td>$80.00</td>
<td>$60.2K</td>
<td>1.9K</td>
<td>20</td>
</tr>
</tbody>
</table>

<h3>About Robinhood Markets</h3>
Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fraud detection, derivatives, fractional shares, recurring investments, and others.
In light of the recent options history for Robinhood Markets, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Robinhood Markets</h3>
<ul>
<li>With a volume of 14,299,051, the price of HOOD is up 1.12% at $83.68. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 41 days.</li>
</ul>
<h3>Expert Opinions on Robinhood Markets</h3>
4 market experts have recently issued ratings for this stock, with a consensus target price of $73.75.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Outperform rating on Robinhood Markets with a target price of $80. 
&#x2A; Consistent in their evaluation, an analyst from Goldman Sachs keeps a Buy rating on Robinhood Markets with a target price of $82. 
&#x2A; An analyst from Deutsche Bank has decided to maintain their Buy rating on Robinhood Markets, which currently sits at a price target of $85. 
&#x2A; Reflecting concerns, an analyst from Redburn Atlantic lowers its rating to Sell with a new price target of $48.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Robinhood Markets, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

HOOD

Robinhood Markets Unusual Options Activity

Offer to acquire substantially all of Sonim's assets for a cash purchase price of $25 million
Purchase price equates to a price per share of $2.418
Hauppauge, New York--(Newsfile Corp. - June 26, 2025) - Orbic North America, LLC ("Orbic"), an international leader in mobile technology innovation, sent a revised acquisition proposal letter to Sonim Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONM#NASDAQ">SONM</a>) ("Sonim" or the "Company"), today in which Orbic re-emphasized Orbic's interest in negotiating a mutually agreeable transaction with Sonim.
In its non-binding proposal, Orbic proposed to purchase substantially all of Sonim's assets for a cash purchase price of $25 million, which equates to a price per share of $2.418. Orbic's proposal is backed by a $50 million financing commitment from a third-party lender. Orbic stated that it is prepared to expeditiously complete confirmatory due diligence and to prepare and negotiate a definitive asset purchase agreement. The Orbic asset purchase offer would not preclude Sonim from additionally proceeding on a parallel path with the Reverse Take-Over transaction announced in its June 25, 2025 press release. The offer is supported by Orbic beneficially owning, together with AJP Holding Company, LLC, approximately 19% of the outstanding common stock of Sonim.
A copy of the revised acquisition proposal and financing commitment letter can be viewed in their entirety on the Securities and Exchange Commission's website at <a href="https://api.newsfilecorp.com/redirect/y4W0WuZWvj">www.sec.gov</a> on Edgar in the Schedule 13D/A filed by Orbic.

Asset Sales

Orbic Proposes $25M Cash Offer To Acquire Sonim Assets; Purchase Price Equates To A Price Per Share Of $2.418

Financial giants have made a conspicuous bullish move on Amazon.com. Our analysis of options history for Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) revealed 51 unusual trades.
Delving into the details, we found 78% of traders were bullish, while 15% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $670,413, and 45 were calls, valued at $9,739,541.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $120.0 and $217.5 for Amazon.com, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Amazon.com's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Amazon.com's whale activity within a strike price range from $120.0 to $217.5 in the last 30 days. 
<h3>Amazon.com Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750957272_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$68.85</td>
<td>$68.8</td>
<td>$68.85</td>
<td>$165.00</td>
<td>$1.7M</td>
<td>4.4K</td>
<td>3.8K</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/27/25</td>
<td>$1.56</td>
<td>$1.5</td>
<td>$1.56</td>
<td>$215.00</td>
<td>$1.5M</td>
<td>31.2K</td>
<td>39.3K</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$68.75</td>
<td>$68.7</td>
<td>$68.75</td>
<td>$165.00</td>
<td>$1.5M</td>
<td>4.4K</td>
<td>3.8K</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$68.75</td>
<td>$68.65</td>
<td>$68.75</td>
<td>$165.00</td>
<td>$866.2K</td>
<td>4.4K</td>
<td>3.8K</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$68.75</td>
<td>$68.7</td>
<td>$68.75</td>
<td>$165.00</td>
<td>$605.0K</td>
<td>4.4K</td>
<td>3.8K</td>
</tr>
</tbody>
</table>

<h3>About Amazon.com</h3>
Amazon is the leading online retailer and marketplace for third party sellers. Retail related revenue represents approximately 75% of total, followed by Amazon Web Services' cloud computing, storage, database, and other offerings (15%), advertising services (5% to 10%), and other the remainder. International segments constitute 25% to 30% of Amazon's non-AWS sales, led by Germany, the United Kingdom, and Japan.
Having examined the options trading patterns of Amazon.com, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Amazon.com Standing Right Now?</h3>
<ul>
<li>With a volume of 19,932,761, the price of AMZN is up 1.72% at $215.64. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 35 days.</li>
</ul>
<h3>Expert Opinions on Amazon.com</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $246.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Oppenheimer has decided to maintain their Outperform rating on Amazon.com, which currently sits at a price target of $250. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Amazon.com, targeting a price of $240. 
&#x2A; An analyst from B of A Securities has decided to maintain their Buy rating on Amazon.com, which currently sits at a price target of $248. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Amazon.com with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Unpacking the Latest Options Trading Trends in Amazon.com

Press Releases

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs

Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics

Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform

Legal

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

Small Cap

AI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the Charge

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform

Smart Healthcare Is Taking Over. Here's Where the Money's Headed

AVAI

CCLD

CCLDO

CERT

GOOG

GOOGL

MSFT

OMDA

POAI

RENB

TREN

Adaptimmune Therapeutics plc - American Depositary Shares

Adaptimmune Therapeutics

Adlai Nortye Ltd. - American Depositary Shares

Adlai Nortye

Armata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals

Alterity Therapeutics Limited - American Depositary Shares

Alterity Therapeutics

CervoMed

Cue Biopharma

Elutia

Forte Biosciences

Gain Therapeutics

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

ImmuCell

IGM Biosciences

Immix Biopharma

Immunic

Opus Genetics

Metagenomi

MediciNova

PDS Biotechnology Corporation - Common Stock

PDS Biotechnology

PMV Pharma

Renovaro

Repare Therapeutics

Serina Therapeutics

Sutro Biopharma

Vor Biopharma

Vistagen Therapeutics, Inc. - Common Stock

Vistagen Therapeutics

Zura Bio Limited - Class A Ordinary shares

Zura Bio

Screenshot 2024-05-06 at 6.05.33 PM

NVDA

Renovaro Inc. (NASDAQ: RENB) Aims To Revolutionize Cancer Detection And Treatment Using Multi-Cancer Detection Model With Nvidia AI Chips For Leadership In Early Detection

Comments

Renovaro

Renovaro (RENB) Opciones

Renovaro (NASDAQ:RENB) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL